Alexander Labrunerie & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.49M Buy
14,276
+1
+0% +$233 1.3% 25
2025
Q4
$2.95M Hold
14,275
1.07% 25
2025
Q3
$2.65M Sell
14,275
-322
-2% -$55.2K 0.98% 27
2025
Q2
$2.23M Buy
14,597
+1
+0% +$154 0.91% 25
2025
Q1
$2.42M Sell
14,596
-129
-0.9% -$20.2K 1.05% 26
2024
Q4
$2.13M Buy
14,725
+1
+0% +$155 0.94% 28
2024
Q3
$2.39M Sell
14,724
-29
-0.2% -$4.62K 1.09% 25
2024
Q2
$2.16M Sell
14,753
-124
-0.8% -$18.4K 1.16% 22
2024
Q1
$2.35M Buy
+14,877
New +$2.37M 1.31% 22

Other funds holding JNJ

Alexander Labrunerie & Co's JNJ Position: Q1 2026 in Review

Alexander Labrunerie & Co increased its Johnson & Johnson (JNJ) stake by 0.01% in Q1 2026, buying an estimated $233 and bringing the position to 14,276 shares worth $3.49M. The position accounts for 1.3% of the portfolio, ranked #25.

Alexander Labrunerie & Co first reported a position in JNJ in Q1 2024 and has held it in 9 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Alexander Labrunerie & Co held 14,276 shares of Johnson & Johnson worth $3.49M as of Q1 2026.
  • Alexander Labrunerie & Co bought 1 Johnson & Johnson share in Q1 2026, an estimated $233.
  • Johnson & Johnson made up 1.3% of Alexander Labrunerie & Co's portfolio in Q1 2026, its #25 holding.
  • Alexander Labrunerie & Co first reported a position in Johnson & Johnson in Q1 2024 and has held it in 9 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Alexander Labrunerie & Co's 13F filing for Q1 2026, filed 18 May 2026.